WT is a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock shows a constructive long-term trend with bullish moving averages, supportive analyst interest, and no negative news pressure. While near-term momentum is mixed, the current setup is still favorable for entering now rather than waiting. Given the investor profile and impatience, I would take the position now and build it as a long-term holding.
WT is in a generally bullish trend because SMA_5 is above SMA_20 and SMA_20 is above SMA_200, which is a positive trend structure. RSI_6 at 61.5 is neutral-to-constructive and does not show overbought conditions. The MACD histogram is slightly negative and expanding lower, which suggests some short-term momentum weakness, but price remains above key support levels around 19.21 and is trading near resistance at 19.73. Overall, the trend is still positive, though not strongly accelerating.

Analysts have recently raised price targets across multiple firms, including Goldman Sachs, Morgan Stanley, Oppenheimer, and Raymond James. Several firms maintain Outperform or equivalent views, citing margin expansion, organic product development, and AUM growth potential. Options positioning is strongly bullish. There was also a recent pre-market positive change in price.
Hedge funds are selling aggressively, with selling up sharply over the last quarter, which is the main negative signal. Morgan Stanley has remained cautious with an Equal Weight view, and Goldman Sachs still rates the stock Neutral despite the target increase. MACD is still slightly weakening, and the stock is near resistance rather than deeply discounted. No recent news catalyst is available for the last week.
No usable financial snapshot was provided because the data returned an error, so the latest quarter financials cannot be assessed directly. As a result, there is no confirmed quarter-over-quarter revenue or earnings trend to evaluate from the provided dataset. The analysis therefore relies more heavily on technicals, options, and analyst revisions.
Analyst sentiment has improved recently. Price targets have been raised by Goldman Sachs, Morgan Stanley, Oppenheimer, and Raymond James, showing a positive revision trend. The Wall Street view is mixed but leaning constructive: Raymond James and Oppenheimer are bullish, while Goldman Sachs and Morgan Stanley remain more neutral/cautious. Net takeaway: pros see upside from AUM growth and margin expansion, but the consensus is not strongly bullish yet.